Kala Pharmaceuticals Tshuag nce 750% hauv 3 hnub tom qab upbeat FDA xov xwm ntawm PCED kev kho mob

Shares ntawm Kala Pharmaceuticals Inc.
KALA,
+ 60.35%
tau rocketed siab dua nyob rau hauv peb-ncaj kev sib tham, mus rau ib tug ntau-ntau tshaj 8-fold nce, txij li thaum lub tuam txhab biopharmaceutical tshaj tawm cov xov xwm zoo txog nws txoj kev kho mob ntawm lub qhov muag tsis pom kev epithelial defect (PCED). Cov khoom lag luam tawg tau nce 218.4% rau hnub Wednesday, tom qab Lub Chaw Tswj Xyuas Khoom Noj thiab Tshuaj tau txais kev tshawb nrhiav tshuaj tshiab (IND) daim ntawv thov rau kev kho PCED, KPI-012, tom qab ntawd nce 99.0% rau hnub Thursday. Hnub Friday, cov khoom lag luam tau nce 34.4% nyob rau nruab nrab kev lag luam rau peb-hnub nce ntawm 751.8%, muab lawv txoj hauv kev los kaw ntawm 7-lub hlis siab. Cov ntaub ntawv pauv hloov tshiab kawg tau pom tias luv luv paj hauv Tshuag, uas tau kaw ntawm cov ntaub ntawv qis ntawm $ 3.67 thaum Lub Kaum Ob Hlis 22, tau nce mus rau xya lub hlis siab ntawm 101,087 shares thaum Lub Kaum Ob Hlis 15, lossis 7.86% ntawm cov pej xeem ntab. Kala cov Tshuag tseem poob 44.8% xyoo rau hnub tim, thaum iShares Biotechnology ETF
IB,
-1.25%
tau poob 14.9% thiab S&P 500
SPX,
-1.13%
tau poob 19.8%.